$CSTE

CSTE Q3'26 Earnings: EPS estimate is (0.16) USD

Caesarstone (CSTE) will report Q3'26 earnings on November 4. Analysts expect revenue of $105.2M and an EPS loss of $0.16. The results will be released before market open.

Original reporting
Published Nov 3, 2026, 12:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 12:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CSTE Q3'26 Earnings: EPS estimate is (0.16) USD — source image
Decision brief

The 30-second read

$CSTEBearishMed
01

Why it matters

The pre‑release estimate provides the first concrete guidance for Q3'26, setting expectations for investors.

02

Market read

First‑report earnings guidance for a micro‑cap; may drive short‑term price movement.

03

What to watch

Potential cost‑saving measures or new contracts not reflected in the estimate could mitigate the downside.

Relevance 6/10Novelty 8/10Timing: pre‑market today

Background

Caesarstone Ltd. (CSTE) is a global manufacturer of engineered stone surfaces, listed on the NYSE.

Company-level read

Ticker impact

$CSTEBearishMedium confidence
Context

CSTE is scheduled to release its Q3'26 earnings estimate (revenue $105.2M, EPS (0.16) USD) before market open on Nov 4.

Expected impact

likely downward pressure as market prices in the negative earnings guidance

Evidence & confidence

Analysts and traders often react to sub‑par earnings guidance, especially for a micro‑cap like Caesarstone.

Market effects

May affect other decorative surfaces and building‑materials stocks if guidance signals broader demand weakness.

Potential impact on Israeli‑listed construction material firms.

Limited to niche building‑materials sector.

Counterpoint

If the market overreacts to the negative EPS, a bounce could occur once actual results are released.

Key entities

  • Caesarstone Ltd.

    Global engineered stone manufacturer.

Related articles

$CSTEMed

Caesarstone Q2 Earnings Call Highlights

Caesarstone (NASDAQ:CSTE) reported Q2 operating expenses of $33.4M (34.6% of revenue). U.S. revenue fell 14.1% to about $42.7M, while Australia rose to $20.3M (up 10.1% constant-currency) and Israel revenue rose 32.4% constant-currency. Net cash was $51.8M. The company cited U.S. tariff changes and ongoing silica-related legal claims.

$CSTEMed

Caesarstone Ltd. (CSTE): Financial results for Q2 2026

Caesarstone Ltd. (CSTE) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Caesarstone Reports Second Quarter 2026 Financial Results - Revenue of $96.6 Million and Gross Margin of 24.0% - - Recently Announced U.S. Quartz Tariff-Rate Quota on Imports, Effective August 15, 2026 - - Evaluating the Impact of New U.S. Tariffs on the Timing of Po

$MDGLMed

Madrigal Swings To Q3 Profit As Rezdiffra Sales Jump 50%

Madrigal Pharmaceuticals (MDGL) reported a Q3 profit of $55.44M, reversing a year-earlier loss, driven by a 50% sales increase of Rezdiffra to $431.30M. R&D expenses declined, while SG&A and cost of sales rose. Over 55,850 patients are now using Rezdiffra, and the company plans a Phase 3 trial for MASH cirrhosis in 2027. MDGL stock is up 9.89%.